Esperion Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ESPR and other ETFs, options, and stocks.

About ESPR

Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. 

CEO
Sheldon L. Koenig
CEOSheldon L. Koenig
Employees
304
Employees304
Headquarters
Ann Arbor, Michigan
HeadquartersAnn Arbor, Michigan
Founded
1998
Founded1998
Employees
304
Employees304

ESPR Key Statistics

Market cap
196.25M
Market cap196.25M
Price-Earnings ratio
-1.24
Price-Earnings ratio-1.24
Dividend yield
Dividend yield
Average volume
2.92M
Average volume2.92M
High today
$1.05
High today$1.05
Low today
$0.9844
Low today$0.9844
Open price
$0.9912
Open price$0.9912
Volume
1.50M
Volume1.50M
52 Week high
$3.94
52 Week high$3.94
52 Week low
$0.6925
52 Week low$0.6925

Analyst ratings

63%

of 8 ratings
Buy
62.5%
Hold
25%
Sell
12.5%

People also own

Based on the portfolios of people who own ESPR. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.